MART-1 (27-35) (human))

CAS No. 156251-11-5

MART-1 (27-35) (human))( ——— )

Catalog No. M40010 CAS No. 156251-11-5

MART-1 (27-35) (human) is an immunogenic epitope recognized by HLA-A2-restricted melanoma-specific tumor-infiltrating lymphocytes (TIL).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    MART-1 (27-35) (human))
  • Note
    Research use only, not for human use.
  • Brief Description
    MART-1 (27-35) (human) is an immunogenic epitope recognized by HLA-A2-restricted melanoma-specific tumor-infiltrating lymphocytes (TIL).
  • Description
    MART-1 (27-35) (human) is an immunogenic epitope recognized by HLA-A2-restricted melanoma-specific tumor-infiltrating lymphocytes (TIL).
  • In Vitro
    MART-1 (27-35) (human) induces melanoma-reactive recognition in cytotoxic T lymphocytes.
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    156251-11-5
  • Formula Weight
    814
  • Molecular Formula
    C37H67N9O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kawakami Y, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med. 1994 Jul 1;180(1):347-52. ?
molnova catalog
related products
  • Biotin-Insulin Recep...

    Biotin-Insulin Receptor (1142-1153), amide

  • FPR A14

    FPR A14 is an agonist of formyl peptide receptor (FPR) and induces cell differentiation.

  • (Rac)-AMG8379

    (Rac)-AMG8379 is a racemate of AMG8379. AMG8379 is a potent, orally active and selective sulfonamide NaV1.7 antagonist(hNaV1.7 and mNaV1.7 with IC50s of 8.5 and 18.6 nM , respectively ).